Image

The HVIP+ Community Model

The HVIP+ Community Model

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The present study will use an optimization randomized control trial design to test the preliminary efficacy of a Hospital-based Violence Intervention Program (HVIP) in Central Arkansas.

Description

Arkansas is a rural southern state with a high toll of homicide relative to its total population (AR ranks 8th nationally in firearm homicide rates). This study will engage community partners throughout Central Arkansas in a multi-level, multi-faceted intervention to reduce the toll of violent assault on individuals and communities. An optimization randomized control trial (ORCT) design will be used to test the preliminary efficacy of a multi-level intervention with an explicit focus on secondary violence prevention through hospital-community partnerships to prevent escalation of firearm violence among survivors living in counties in Central Arkansas, the region of the state where violent assault is greatest. The study will also incorporate key implementation science metrics to evaluate the feasibility and reach of the proposed intervention.

Eligibility

Inclusion Criteria:

  • Be at least 18 years of age or older
  • Currently live in Central Arkansas
  • Currently being treated for a penetrating gun assault injury at a local hospital

Exclusion Criteria:

Participants must not:

  • Report any medical problems that would limit their ability to express thoughts and answer questions (i.e. active intoxication, developmental delays, dementia, psychosis, etc.)
  • Be currently under arrest or in police custody

Study details
    Hospital-based Violence Intervention
    Community Firearm Violence
    Firearm Behaviors

NCT07539142

University of Arkansas

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.